News

Cognitive Decline May Start at Age 45

View on the News

A Case for Earlier Dementia Prevention

The authors of this study have set a new benchmark for pinpointing cognitive decline in younger adults, both for future research studies and eventually for efforts to prevent dementia in clinical practice.

It will be a major challenge to design prospective research studies that include much younger age groups than are currently assessed in studies of cognitive decline, because of the modest differences in cognition that are expected across risk factors for cognitive decline in middle-aged people. Studies that aim to understand risk factors for – and determinants of – cognitive decline beginning at middle age will need to incorporate probably tens of thousands of participants to be able to detect the variables that influence brain health at these younger ages. For such large studies, the use of face-to-face cognitive interviews may need to give way to new research methods that adapt tests for telephone use or be administered through a computer.

Francine Grodstein, Sc.D., is an epidemiologist at Brigham and Women’s Hospital in Boston. These comments were adapted from an editorial accompanying the study (BMJ 2012 Jan. 5 [doi:10.1136/bmj.d7652]). Dr. Grodstein had no financial conflicts to disclose.


 

FROM THE BRITISH MEDICAL JOURNAL

Measurable cognitive decline may begin as early as 45 years of age, according to data from a 10-year study of more than 7,000 adults.

Previous studies have shown limited evidence of cognitive decline before age 60 years, "but the age at which cognitive decline becomes evident at the population level remains the subject of debate," Dr. Archana Singh-Manoux of the Institut National de la Santé et de la Recherche Médicale in Villejuif, France, and her colleagues wrote Jan. 5 in the British Medical Journal.

The scores in most areas (memory, reasoning, and phonemic and semantic fluency) – with the exception of vocabulary – significantly declined in all age groups for both men and women. Controlling for education had no significant impact on the findings.

Of note, reasoning declined by 3.6% in both men and women aged 45-49 years at baseline. By comparison, mental reasoning declined by 9.6% in men aged 65-70 years at baseline, and by 7.4% in women aged 65-70 years at baseline.

The study participants were part of the Whitehall II cohort, a population of British civil servants established in 1985. The study included 5,198 men and 2,192 women who were aged 45-70 years in 1997-1999, when they began cognitive testing (BMJ 2012 Jan. 5 [doi:10.1136/bmj.d7622]).

Cognitive testing consisted of three clinical examinations conducted over 10 years. Each examination included the Alice Heim 4-I (a test of verbal and mathematical reasoning); a test of short-term verbal memory (writing in a 2-minute period as many words as possible from a list of 20 that had been spoken to them); a test of phonemic fluency (writing as many words beginning with "S" as possible in 1 minute); semantic fluency (writing as many animal names as possible in 1 minute); and the Mill Hill vocabulary test.

Although the findings may not be generalizable because of the homogenous, white-collar study population, the results suggest that paying more attention to dementia risk factors such as obesity, hypertension, and high cholesterol in midlife may be more important than previously thought, the researchers noted. Further studies are needed to determine how and whether cognitive trajectories can be modified, and to identify the best age window for successful interventions, they said.

The researchers had no financial conflicts to disclose. The Whitehall II study is supported by a grant from the British Medical Research Council and the British Heart Foundation.

Recommended Reading

Contraception Affects Seizures in Women With Epilepsy
MDedge Internal Medicine
Discoveries Could Slow Dysfunction in Spinocerebellar Ataxia Type 1
MDedge Internal Medicine
Barriers to Epilepsy Care Continue to Frustrate
MDedge Internal Medicine
Urinary Dysfunction Stands Out on Retigabine's Safety Profile
MDedge Internal Medicine
Patient Died Soon After Taking MS Drug Fingolimod
MDedge Internal Medicine
More Than 40% of Police Officers Have Sleep Disorders
MDedge Internal Medicine
Hospital Infections Sharply Increase Death in Status Epilepticus
MDedge Internal Medicine
Technique Maps Neural Connectivity to Detect Seizure Foci
MDedge Internal Medicine
Emergency Physician Works to Unravel Mysteries Behind Concussions
MDedge Internal Medicine
Flu Still a Killer for Neurologically Impaired Young People
MDedge Internal Medicine